Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the pharmacokinetic parameters and safety of topical MM36 (OPA-15406) ointment in pediatric subjects with atopic dermatitis under maximal use conditions.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medimetriks Pharmaceuticals, Inc
NCT07223697 · Atopic Dermatitis
NCT07455578 · Autoimmune Diseases, Rheumatoid Arthritis (RA), and more
NCT02504853 · Food Allergy, Loeys-Dietz Syndrome, and more
NCT07355075 · Eczema Atopic Dermatitis, Eczema, and more
NCT04455906 · Atopic Dermatitis
Medimetriks Investigational Site
Fremont, California
Medimetriks Investigational Site
Irvine, California
Medimetriks Investigational Site
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions